Deal ✓152 - IPO Array - solar powered +$ 5,000 per day!Stock market. Stocks. IPO Array Technologies (ARRY) — on October 14, 2020, the IPO of Array Technologies will take place. The company is one of the world's largest manufacturers of ground — mounted systems for solar energy projects-solar trackers. The placement is underwritten by Goldman Sachs, JPMorgan, Guggenheim Securities and Morgan Stanley. The deadline for submitting an order with the broker is until 20-00 Moscow time on 13.10.2020, the start date of trading is 15.10.2020.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to get more information, please write in private messages.
Keywords: IPO, opportunity, insider, profit
IPO
$IH is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
iHuman provides an online childhood edutainment destination for children in China.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $13,12;
stop-loss — $11,55;
take-profit — $17,83.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
🌀 Deal ✓141 - IPO of Spruce Biosciences (SPRB) another biotech!Stock market. Stocks. IPO of Spruce Biosciences (SPRB) — on October 09, 2020, shares of a Company developing new treatments for rare endocrine diseases will start trading on the American stock exchange. The placement is underwritten by Cowen, SVB Leerink, Credit Suisse and RBC Capital Markets. The deadline for submitting an application with the broker is 20-00 Moscow time 07.10.2020, the placement date is 08.10.20
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.
Company: Spruce Biosciences, Inc. (SPB) boutique
rating: 3
Scoop rating: 2
Oversubscribed: oversubscribed (100% )
LONG CITRON is giving a GREAT LONG opportunity with $CMPSCitron following intraday trading strategy idea
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.
The share price is rising and gonna continue this trend today after the new Citron report publishing.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $41,92;
take-profit — $51,88;
stop-loss — $38,59
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$PLTR is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Palantir Technologies is a data analytics software company.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $11,13;
stop-loss — $9,71;
take-profit — $15,39 or MOC price.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$CD is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Chindata Group Holdings builds and operates hyper-scale data centers in China, Malaysia, and soon in India.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $14,66;
stop-loss — $13,66;
take-profit — 17,66.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$ASAN is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Asana is a work management company.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $29,37;
stop-loss — $26,63
take-profit — MOC price
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$AVO is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Mission Produce is a world leader in sourcing, producing, and distributing fresh avocados, servicing retail, wholesale, and foodservice customers in over 25 countries.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $13,45;
stop-loss — $11,82;
take-profit — $18,34.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Deal 115 - IPO 4 Therapeutics (CCCC) -money for cancer treatmentStock market. Stocks. IPO of C4 Therapeutics (CCC) — October 02, 2020 will start trading on the US NASDAQ stock exchange for the company that develops new cancer treatments by using the natural regulation of protein in the body. The placement is underwritten by Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank. The deadline for submitting an application with the broker is 20-00 Moscow time 30.09.2020, the placement date is 01.10.2020.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.
$PRLD is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Prelude Therapeutics is a clinical-stage biopharma developing treatments for various cancers.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $26,25;
stop-loss — $22,94;
take-profit — $36,18.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
AMST: Decent IPO EntryAny entry for AMST under $5.50 I believe is decent. I think the stock is poised to go up and garnish some major support levels. Current target is at 115% current price. It is mid to high risk for an IPO surge, but I feel like the support level patterns at open usually follows that of the IPOs expected to garnish surge support. That being said, do your own due diligence and invest at your own risk. Consider everything I say on the basis of opinion.
$BSY is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Bentley Systems provides infrastructure engineering software to clients worldwide.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $29,77;
stop-loss — $25,77;
take-profit — $41,77.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
$GDRX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
GoodRx is a platform for prescription price comparison and negotiating with pharmacy benefits managers (PBM) to receive cost-savings for its users.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $49,5;
stop-loss — $45,5;
take-profit — $61,5.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
🌀 Attention! Deal °86 IPO Prelude T. - for cancer treatment!Stock market. Stocks. IPO Prelude Therapeutics — (PRLD) - September 25, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 23.09.2020), which develops drugs for the treatment of cancer. The placement is underwritten by Morgan Stanley, Goldman Sachs and Bofasecuries. Company: Prelude Therapeutics (PLC) is a boutique Rating: 3 stars out scoop: 2 Oversubscription: 100% Allocation: up to 20%
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
🌀 Attention! Deal °85-IPO of Taisha Gene Therapy (THE) biotechsStock market. Stocks. IPO Taysha Gene Therapies — TSHA) - September 24, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 14-00 Moscow time on 23.09.2020), which specializes in the development of methods for treating the Central nervous system through gene therapy. The placement is underwritten by Goldman Sachs, Morgan Stanley and Jefferies. Boutique rating:3 scoop Rating: 2 Oversubscription: 200% Allocation: up to 50%
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF in the Fund (additional data on request in PM)
BUY STOCKS NAS100 ANALYSISAs u can see on the day chart this flush can continue down to 9900 and than retrace back in to the bullish mode, it could also retrace from now hitten support and that mean, now is the best time to buy some stocks. Be carefull and watch the support if a are trading with leverage but when u investing its safer.
Hope this perespective will help you with trading stocks! If it will give me a like and share your toughts with me and other traders in comments!
$CMPS is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
COMPASS Pathways is developing a drug treatment for treatment-resistant depression .
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $25,00;
stop-loss — $20,00
information about take-profit will be later
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Unity Software: Support Line at $68Unity is one of those unique cases where I wanted to invest, but the opening seemed too high. Now for a long position, a decent entry target for riding a wave might be at $68 with potential correlation patterns upwards to $70+. If I were still interested, I would likely do buy at $68, with target to $85 and a stop loss at $66.25. That being said, do your own due diligence and invest at your own risk.
Support Line for Sumo @ $25Right now, currently I think that the support line for SUMO which I called yesterday is $25 as a decent entry. $25 being a bit pricier than the $22 expected open price, but still quite reasonable for a long position. I think resistance may not pop it more then that point. That being said, do your own due diligence and invest at your own risk. Consider everything I say "as is" or on an opinion based basis.